After successful Phase 3 trials, Indevus Pharmaceuticals Inc. has received a $10 million milestone payment from its partner in the development of overactive-bladder drugs Sanctura and Sactura XR, ...

A new study suggests that more women are being prescribed beta-3 agonists over anticholinergics for the treatment of overactive bladder (OAB), suggesting that more clinicians may be choosing this ...

If frequent bathroom trips disrupt your life, you are not alone. Women's health expert Kirtly Jones, MD, talks to urogynecologist Whitney Hendrickson, MD, about the complexities of overactive bladder ...

TOKYO, June 18 (Reuters) - Japan's Astellas Pharma <4503.T> said on Friday it was seeking approval from Japanese health authorities for a bladder control drug. Sign up here. The company said it was ...